Understanding how certain brain receptors work and can be targeted for treatment
Quantitative analysis of metabotropic glutamate receptor activation and modulation
This study is looking at special brain receptors that could help us find new ways to treat conditions like anxiety and autism by watching how they work in real-time, which might lead to better treatments for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-10914176 on NIH RePORTER |
What this research studies
This research investigates metabotropic glutamate receptors (mGluRs), which play a crucial role in brain signaling and are potential targets for treating various neurological disorders. By developing a novel technology to observe these receptors in real-time under physiological conditions, the research aims to quantify how these receptors change shape and activate specific signaling pathways. This approach could lead to better understanding and modulation of mGluRs, which are implicated in conditions like anxiety, autism, and certain cancers. Patients may benefit from new therapeutic strategies that arise from this enhanced understanding of receptor function.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with neurological disorders such as autism, anxiety, or schizophrenia.
Not a fit: Patients with conditions unrelated to the functioning of metabotropic glutamate receptors may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new treatments for neurological disorders and certain cancers.
How similar studies have performed: Other research has shown success in targeting GPCRs for drug development, indicating that this approach has potential for significant breakthroughs.
Where this research is happening
Chicago, UNITED STATES
- Northwestern University — Chicago, United States (Active)
Researchers
- Principal investigator: Vafabakhsh, Reza — Northwestern University
- Study coordinator: Vafabakhsh, Reza
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.